2022
DOI: 10.7860/jcdr/2022/57397.17139
|View full text |Cite
|
Sign up to set email alerts
|

Ocular Manifestations in Psoriasis Patients Attending a Tertiary Care Centre, Srikakulam, Andhra Pradesh, India: A Cross-sectional Study

Abstract: Introduction: Psoriasis is known to be proliferative, relapsing inflammatory disorder affecting mainly skin and other parts of body. There are several co-morbidities associated with psoriasis, of which ocular findings go unnoticed. Aim: To study the spectrum of ocular manifestations in psoriasis patients in Srikakulam, north coastal region of Andhra Pradesh, India and also to identify relationship between frequency of ocular involvement in psoriasis patients with age, gender, type and severity of psoriasis. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The majority of the patients, 49 (61.25%), were between the ages of 25 and 50, while 25 (31.25%) were between the ages of 50 and 75. 15 The psoriasis duration ranged from 1 month to 35 years in a research by Abbagani et al, with a mean length of 10.56 ± 7.4 years. 16 The study's findings revealed a dry eye prevalence of 63.1%, with varying degrees of severity: 24.4% classified as mild, 46.3% as moderate, and 29.3% as severe.…”
Section: Discussionmentioning
confidence: 97%
“…The majority of the patients, 49 (61.25%), were between the ages of 25 and 50, while 25 (31.25%) were between the ages of 50 and 75. 15 The psoriasis duration ranged from 1 month to 35 years in a research by Abbagani et al, with a mean length of 10.56 ± 7.4 years. 16 The study's findings revealed a dry eye prevalence of 63.1%, with varying degrees of severity: 24.4% classified as mild, 46.3% as moderate, and 29.3% as severe.…”
Section: Discussionmentioning
confidence: 97%